Abstract
Deacylketoconazole was 15- to 50-fold more active against Plasmodium falciparum than was ketoconazole, based on [3H]hypoxanthine uptake and quantitative parasite counts. In contrast, there were no significant differences between these drugs in their activity against clinical isolates of Candida spp.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berman J. D. Activity of imidazoles against Leishmania tropica in human macrophage cultures. Am J Trop Med Hyg. 1981 May;30(3):566–569. doi: 10.4269/ajtmh.1981.30.566. [DOI] [PubMed] [Google Scholar]
- Borelli D., Bran J. L., Fuentes J., Legendre R., Leiderman E., Levine H. B., Restrepo A., Stevens D. A. Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs. Postgrad Med J. 1979 Sep;55(647):657–661. doi: 10.1136/pgmj.55.647.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brass C., Shainhouse J. Z., Stevens D. A. Variability of agar dilution-replicator method of yeast susceptibility testing. Antimicrob Agents Chemother. 1979 Jun;15(6):763–768. doi: 10.1128/aac.15.6.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Desjardins R. E., Canfield C. J., Haynes J. D., Chulay J. D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979 Dec;16(6):710–718. doi: 10.1128/aac.16.6.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dixon D., Shadomy S., Shadomy H. J., Espinel-Ingroff A., Kerkering T. M. Comparison of the in vitro antifungal activities of miconazole and a new imidazole, R41,400. J Infect Dis. 1978 Aug;138(2):245–248. doi: 10.1093/infdis/138.2.245. [DOI] [PubMed] [Google Scholar]
- Holbrook W. P., Kippax R. Sensitivity of Candida albicans from patients with chronic oral candidiasis. Postgrad Med J. 1979 Sep;55(647):692–694. doi: 10.1136/pgmj.55.647.692. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jordan W. M., Bodey G. P., Rodriguez V., Ketchel S. J., Henney J. Miconazole therapy for treatment of fungal infections in cancer patients. Antimicrob Agents Chemother. 1979 Dec;16(6):792–797. doi: 10.1128/aac.16.6.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pfaller M. A., Krogstad D. J. Imidazole and polyene activity against chloroquine-resistant Plasmodium falciparum. J Infect Dis. 1981 Oct;144(4):372–375. doi: 10.1093/infdis/144.4.372. [DOI] [PubMed] [Google Scholar]
- Scheibel L. W., Ashton S. H., Trager W. Plasmodium falciparum: microaerophilic requirements in human red blood cells. Exp Parasitol. 1979 Jun;47(3):410–418. doi: 10.1016/0014-4894(79)90094-8. [DOI] [PubMed] [Google Scholar]
- Trager W., Jensen J. B. Human malaria parasites in continuous culture. Science. 1976 Aug 20;193(4254):673–675. doi: 10.1126/science.781840. [DOI] [PubMed] [Google Scholar]
- Trager W., Robert-Gero M., Lederer E. Antimalarial activity of S-isobutyl adenosine against Plasmodium falciparum in culture. FEBS Lett. 1978 Jan 15;85(2):264–266. doi: 10.1016/0014-5793(78)80469-4. [DOI] [PubMed] [Google Scholar]
- Van Cutsem J. M., Thienpont D. Miconazole, a broad-spectrum antimycotic agent with antibacterial activity. Chemotherapy. 1972;17(6):392–404. doi: 10.1159/000220875. [DOI] [PubMed] [Google Scholar]
- Van Der Meer J. W., Keuning J. J., Scheijgrond H. W., Heykants J., Van Cutsem J., Brugmans J. The influence of gastric acidity on the bio-availability of ketoconazole. J Antimicrob Chemother. 1980 Jul;6(4):552–554. doi: 10.1093/jac/6.4.552. [DOI] [PubMed] [Google Scholar]
